SCHEMBL3379883

SCHEMBL3379883

CC(C)(C)[Si](C)(C)OCCNc1ccc(CN2Cc3cccc(NC(=O)c4ccc(Cl)s4)c3C2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.47
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
TP53 P04637 2/20 0.36
USP2 O75604 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAPK1 P28482 2/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 5/20 0.35
MCL1 Q07820 1/20 0.35
NR1I2 O75469 1/20 0.35
UGCG Q16739 1/20 0.35
HDAC1 Q13547 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HPGD P15428 1/20 0.35
POLB P06746 2/20 0.34
LMNA P02545 1/20 0.34
CREBBP Q92793 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3380722 0.94 F10 (0.48) F10KMT2AMEN1MAPTTP53
SCHEMBL3381165 0.89 POLB (0.40) F10MAPTTP53TDP1SMN1; SMN2
SCHEMBL3379830 0.85 F10 (0.40) F10KMT2AMEN1MAPTTP53
SCHEMBL3377544 0.85 F10 (0.51) F10KMT2AMEN1MAPTTP53
SCHEMBL3381123 0.82 F10 (0.43) F10KMT2AMEN1MAPTTP53
SCHEMBL3378168 0.82 F10 (0.63) F10KMT2AMEN1MAPK1ALDH1A1
SCHEMBL3376468 0.81 AHR (0.40) F10MAPK1ALDH1A1SMN1; SMN2HPGD
SCHEMBL3377124 0.80 F10 (0.49) F10ALDH1A1SMN1; SMN2HPGD
SCHEMBL3382279 0.80 F10 (0.49) F10KMT2ATP53MAPK1TSHR
SCHEMBL3379941 0.78 F10 (0.53) F10KMT2AMEN1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029586-B1 ISOINDOLIN-1-ONE-, ISOINDOLIN-3-ONE- AND ISOINDOLIN-1,3-DIONE-DERIVATIVES AND USE THEREOF BAYER SCHERING PHARMA AG (DE) 2010-11-24 EP disclosed
US-20100010060-A1 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2010-01-14 US disclosed
US-20100010060-A1 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100010060-A1 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof ICAM1, SERPINC1, TFPI2 F10 264/4885KMT2A 4409/4885MEN1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.